Work

PS5-09-28: Capecitabine for Targeted Eradication of aRising ctDNA Molecular Residual Disease in ER-positive/HER2-negative Early-stage Breast Cancer

Year: 2026

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-09-28

Authors: M. J. Elliott, E. Amir, M. B. Nadler, M. Li, C. Yu, M. Audoin, G. Putcha, W. Levin, S. Birkeäl, K. Howarth, P. Bedard, L. L. Siu, H. Berman, C. Townsley, M. Wu, D. W. Cescon

Institutions: Princess Margaret Cancer Centre, Women's College Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129428500

FWCI: 2.634

Cites:

Cited by: 1

Related to: